Search Details

Word: tumor (lookup in dictionary) (lookup stats)
Dates: during 2000-2009
Sort By: most recent first (reverse)


Usage:

...better that researchers know a cancer, the better their chances of defeating it. Those odds also improve if doctors have more than one way to fight it. As they fill in the details--at the molecular level--of the world in which tumors thrive, doctors are becoming convinced that a one-drug-one-cancer approach is not sufficient. Just as AIDS physicians currently use a multi-drug approach to attack HIV at different stages of its life cycle, so too are cancer doctors beginning to surround tumor cells with combinations of agents that can weaken a growing cancer by chipping...

Author: /time Magazine | Title: Health: Surviving Cancer | 6/21/2004 | See Source »

...that takes about 40 sec. produces 870 images of the internal organs. Freilich analyzes the images for signs of illness, specifically heart disease, spinal abnormalities and cancer. One X ray of Don's left kidney stunned Freilich. "What the hell is that?" he said aloud. Freilich had spotted a tumor that, at the press of a key, he measured at an enormous 8 cm in diameter. Freilich phoned his friend. "Would you like to come over and see your pictures?" "No." "You should. They're interesting...

Author: /time Magazine | Title: What Lies Within | 6/1/2004 | See Source »

...supplements of estrogen, unlike the combination of estrogen and progestin, did not appear to increase a woman's risk of breast cancer. Perhaps estrogen pills work more selectively in the body than anyone had realized. Or perhaps the type of progestin used in studies was more likely to trigger tumor growth...

Author: /time Magazine | Title: Estrogen Redux | 5/3/2004 | See Source »

...patient has a mutation in the human gene known as epidermal growth factor receptor (EGFR), Iressa has a much greater chance of slowing the growth of that patient’s tumor, the report said...

Author: By Matthew S. Meisel, CONTRIBUTING WRITER | Title: Cancer Drug’s Success Explained | 4/30/2004 | See Source »

Johnson said the discovery of the linkage between the EGFR mutation and the drug effectiveness will reduce indiscriminate use of Iressa. “Before you decide to treat [a patient], you can sequence their tumor tissue for the appropriate mutation,” he said...

Author: By Matthew S. Meisel, CONTRIBUTING WRITER | Title: Cancer Drug’s Success Explained | 4/30/2004 | See Source »

Previous | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | Next